Cabaletta Bio, Inc. (NASDAQ:CABA) has seen 2,291,193 shares traded in the last trading session. The company, currently valued at $262.45 Million, closed the last trade at $10.92 per share which meant it gained $1.14 on the day or 11.66% during that session. The CABA stock price is -79.76% off its 52-week high price of $19.63 and 49.54% above the 52-week low of $5.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 440.14 Million shares traded. The 3-month trading volume is 142.97 Million shares.

The consensus among analysts is that Cabaletta Bio, Inc. (CABA) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 3 have rated it as a Hold, with 3 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.33.

Cabaletta Bio, Inc. (NASDAQ:CABA) trade information

Sporting 11.66% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Jun 26 when the CABA stock price touched $12.00- or saw a rise of 9%. Year-to-date, Cabaletta Bio, Inc. shares have moved -21.83%, while the 5-day performance has seen it change 27.42%. Over the past 30 days, the shares of Cabaletta Bio, Inc. (NASDAQ:CABA) have changed 45.41%. Short interest in the company has seen 276.25 Million shares shorted with days to cover at 1.93.

Wall Street analysts have a consensus price target for the stock at $22, which means that the shares’ value could jump 101.47% from current levels. The projected low price target is $19 while the price target rests at a high of $25. In that case, then, we find that the current price level is +128.94% off the targeted high while a plunge would see the stock lose 73.99% from current levels.

Cabaletta Bio, Inc. (CABA) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest -71.3% while over the next 5 years, the company’s earnings are expected to increase by 0%.

Cabaletta Bio, Inc. (NASDAQ:CABA)’s Major holders

Insiders own 14.29% of the company shares, while shares held by institutions stand at 68.02% with a share float percentage of 79.37%. Investors are also buoyed by the number of investors in a company, with Cabaletta Bio, Inc. having a total of 55 institutions that hold shares in the company. The top two institutional holders are 5AM Venture Management, LLC with over 3.67 Million shares worth more than $26.79 Million. As of March 30, 2020, 5AM Venture Management, LLC held 15.27% of shares outstanding.

The other major institutional holder is Adage Capital Partners GP L.L.C., with the holding of over 3.6 Million shares as of March 30, 2020. The firm’s total holdings are worth over $26.31 Million and represent 15% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and iShares Russell 2000 ETF. As of March 30, 2020, the former fund manager holds about 0.81% shares in the company for having 195342 shares of worth $1.43 Million while later fund manager owns 148.89 Thousand shares of worth $1.09 Million as of March 30, 2020, which makes it owner of about 0.62% of company’s outstanding stock.